Meritage Portfolio Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,694
Closed -$6.64M 325
2022
Q4
$6.64M Sell
27,694
-404
-1% -$90.5K 0.52% 63
2022
Q3
$5.16M Sell
28,098
-1,224
-4% -$244K 0.43% 72
2022
Q2
$4.93M Buy
29,322
+9,247
+46% +$1.99M 0.38% 87
2022
Q1
$5.03M Buy
+20,075
New +$5.04M 0.31% 102

Other funds holding HCA

Meritage Portfolio Management's HCA Position: Q1 2023 in Review

Meritage Portfolio Management sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 27,694 shares — an estimated $6.64M sold.

Meritage Portfolio Management first reported a position in HCA in Q1 2022 and held it in 4 quarters. The position peaked at $6.64M in Q4 2022. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Meritage Portfolio Management reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Meritage Portfolio Management sold 27,694 HCA Healthcare shares in Q1 2023, an estimated $6.64M.
  • Meritage Portfolio Management first reported a position in HCA Healthcare in Q1 2022 and held it in 4 quarters.
  • Meritage Portfolio Management's HCA Healthcare position peaked at $6.64M in Q4 2022.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Meritage Portfolio Management's 13F filing for Q1 2023, filed 25 Apr 2023.